Product Features:
| Product Name | Simendan |
| Generic Name | Levosimendan INN |
| Formulation | Injection |
| Available Pack Size | 1's |
| Available Strength | 5 mL |
| Registrations | Bangladesh |
-
Product Description: Simendan is indicated for the short-term treatment of Acute Heart Failure (AHF) in situations where conventional therapy is not sufficient, and in cases where inotropic support is considered appropriate. For product leaflet please click in this below link: Simendan Insert
Product Features:
-
Product Description: BML is Lunching Apalunix 60 mg tablet which is an androgen receptor inhibitor indicated for the treatment of patients with- Metastatic castration-sensitive prostate cancer
- Non-metastatic castration resistant prostate cancer.
Product Name Apalunix Generic Name Apalutamide INN Formulation Tablet Available Pack Size 120's pot Available Strength 60 mg Registrations Available Website Apalunix.com -
Product Description: Ribociclib 200 mg (Ribotix) is a CDK4/6 inhibitor that is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Ribociclib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of Cancer cells. Product Features:Product Name Ribotix Generic Name Ribociclib Formulation Tablet Available Pack Size 63's pot Available Strength 200 mg Registrations Available -
Product Description: Pembroxim, is found in injection form, under the generic of Pembrolizumab, to help patients fighting against the infection of certain types of cancer in the world. The medicine will be used in cancer immunotherapy that includes melanoma, head and neck cancer, Hodgkin lymphoma and stomach cancer. It is suggested for slow injection into vein of the patients. Product Features:Product Name Pembroxim Generic Name Pembrolizumab Formulation Injection Available Pack Size 1's Vial Available Strength 100 mg/4ml Registrations Available -
Product Description: Nindanix is indicated for the treatment of locally advanced, metastatic or locally recurrent non-small cell lung cancer (NSCLC) adenocarcinoma type in combination with docetaxel for the treatment of adult patients after the failure of first-line chemotherapy. Product Features:Product Name Nindanix Generic Name Nintedanib Formulation Capsule Available Pack Size 80 & 50 Capsule Available Strength 100 mg, 150 mg Registrations Available -
Product Description: Niraparix is a once-daily, oral medicine used for the maintenance treatment of women with recurrent ovarian, fallopian tube, or primary peritoneal cancer when their cancer comes back. Niraparix is the first and only once-daily PARP inhibitor used after the cancer has responded (complete or partial response) to treatment with platinum-based chemotherapy Product Features:Product Name Niraparix Generic Name Niraparib Formulation Capsule Available Strength 100 mg Registrations Available -
Product Description: Alectinib is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to Crizotinib. Alectinib as monotherapy is indicated for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). Product Features:Product Name Alecinix Generic Name Alectinib Formulation Capsule Available Strength 150 mg Registrations Available Website alecinix.com -
Product Description: Nilotinib (Nilonix) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Nilotinib is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML) in adults and children who are at least 1 year old. Nilotinib is usually given after other medications have been tried without success. Product Features:Product Name Nilonix Generic Name Nilotinib Formulation Capsule Available Pack Size 120 Capsule Available Strength 150 mg, 200 mg Registrations Available Website: nilonix.com -
Product Description: BRIGANIX is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. Product Features:Product Name Briganix Generic Name Brigatinib Formulation Tablet Available Pack Size 30’s Pot Available Strength 90 mg, 180 mg Registrations Available Website: Briganix.com -
Product Description: Renesis (Roxadustat) is a the first-in-class, oral tablet that promotes erythropoiesis through the endogenous production of erythropoietin (EPO) near physiological range. Upon administration, roxadustat binds to and inhibits HIF-PH (Prolyl Hyroxylase) , an enzyme responsible for the degradation of transcription factors in the HIF family under normal oxygen conditions. This prevents HIF breakdown and promotes HIF activity. Increased HIF activity leads to an increase in endogenous erythropoietin Production. It also upregulates the distribution, metabolism and absorption of iron within the body as well as downregulates hepcidin which is responsible for improper intracellular iron transportation. Therefore, Renesis (Roxadustat) can induce endogenous production of mature HB plump with iron. Renesis (Roxadustat) is indicated for treatment of adult patients with systematic anemia and functional iron deficiency anaemia associated with chronic kidney disease (CKD), Chemotherapy induced anemia and chronic disease induced anemia. Reneis (Roxadust) also improves hypo responsiveness of ESA in CKD patients. Product Features:Product Name Renesis Generic Name Roxadustat INN Formulation Oral Tablet Available Pack Size 3’s Available Strength 20 mg, 50 mg, 70mg & 100 mg Registrations Bangladesh -
Product Description: Ribociclib 200 mg (Ribotix) is a CDK4/6 inhibitor that is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Ribociclib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of Cancer cells. Product Features:Product Name Ribotix Generic Name Ribociclib Formulation Tablet Available Pack Size 63’s Pot Available Strength 200 mg Registrations Available -
Product Description: Enzalutamide (Enzalunix) a non-steroidal anti-androgen medication that is used in the treatment of prostate cancer. Enzalunix is a hormonal therapy which is indicated for metastatic castration-sensitive prostate cancer (mCSPC), metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). Product Features:Product Name Enzalunix Generic Name Enzalutamide Formulation Tablet Available Pack Size 120’s Pot Available Strength 40 mg Registrations Available